| A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. | |
| | |
MedLine Citation:
|
PMID: 19874316 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Solar lentigines are common, benign, cosmetically disfiguring lesions. Available physical treatments are effective, but they are costly and carry risks of side-effects. OBJECTIVE: To evaluate the efficacy and safety of a preparation containing undecylenoyl phenylalanine 2% in the topical treatment of solar lentigines. METHODS: In total, 36 patients with solar lentigines of the hands were randomly assigned to apply the active preparation on one side and the vehicle alone on the other side, twice daily for 12 weeks. Patients were evaluated monthly for efficacy and safety. RESULTS: In all, 30 patients (28 women and 2 men; age range 47-75 years) completed the study. The duration of lesions ranged from 8 months to > 10 years. All patients responded partially on the side of the active treatment. Of the partial responders, 19 (63.3%) had moderate improvement and 11 (36.6%) had marked improvement. Improvement was evident from the first follow-up visit. On the side of the vehicle, 26 remained stable (86.6%) and 4 (13.3%) had partial improvement. There was a significant difference (P < 0.01) in efficacy of the active preparation vs. the vehicle. Using patient assessment ratings, 80% were 'much more satisfied/more satisfied' with the result. The reported side-effects were minor and included erythema and itching or burning on the side of active treatment. CONCLUSIONS: Undecylenoyl phenylalanine 2% is a novel depigmenting agent, which possibly acts as an alpha-melanocyte-stimulating hormone antagonist, thus inhibiting melaninogenesis. It achieved a significant lightening of the lesions with minimal side-effects. Most patients were satisfied with the improvement. Undecylenoyl phenylalanine 2% may represent a safe, effective and inexpensive therapeutic alternative for solar lentigines. |
| | |
Authors:
|
A C Katoulis; A Alevizou; E Bozi; M Makris; A Zafeiraki; N Mantas; F Kousta; M Mistidou; A Kanelleas; N G Stavrianeas |
Related Documents
:
|
22582226 - Shortcuts in arthroscopic knot tying: do they affect knot and loop security? 14725326 - Ajoene and 5-fluorouracil in the topical treatment of cladophialophora carrionii chromo... 12182256 - A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel f... 12207676 - Positive effect of using calcipotriol ointment with narrow-band ultraviolet b photother... 23603826 - 5-fluorouracil augmented needle revision of trabeculectomy: does the location of outflo... 23277386 - Risk factors and clinical analysis for invasive fungal infection in neonatal intensive ... |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial Date: 2009-10-23 |
Journal Detail:
|
Title: Clinical and experimental dermatology Volume: 35 ISSN: 1365-2230 ISO Abbreviation: Clin. Exp. Dermatol. Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-07-20 Completed Date: 2011-01-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7606847 Medline TA: Clin Exp Dermatol Country: England |
Other Details:
|
Languages: eng Pagination: 473-6 Citation Subset: IM |
Affiliation:
|
Second Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, Attikon University General Hospital, Athens, Greece. alexanderkatoulis@yahoo.co.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Chi-Square Distribution Dermatologic Agents / therapeutic use* Double-Blind Method Female Humans Lentigo / drug therapy* Male Middle Aged Phenylalanine / analogs & derivatives*, therapeutic use* Sunlight / adverse effects Treatment Outcome alpha-MSH / antagonists & inhibitors* |
| Chemical | |
Reg. No./Substance:
|
0/Dermatologic Agents; 581-05-5/alpha-MSH; 63-91-2/Phenylalanine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: c-Ski promotes skin fibroblast proliferation but decreases type I collagen: implications for wound h...
Next Document: Are dark-skinned people really protected from ultraviolet radiation?